MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference

VALENCIA, Calif.--(BUSINESS WIRE)-- MannKind Corporation (NAS: MNKD) , focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at The Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2013 at 3:30 PM (ET) at the Grand Hyatt Hotel in New York City.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at

About MannKind Corporation

MannKind Corporation (NAS: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product candidate, AFREZZA®, has completed Phase 3 clinical trials. MannKind maintains a website at to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

MannKind Corporation
Matthew Pfeffer
Chief Financial Officer
(661) 775-5300

KEYWORDS:   United States  North America  California  New York


The article MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Increase your money and finance knowledge from home

Introduction to Economic Indicators

Measure the performance of the economy.

View Course »

Reading a Stock Quote

Learn to read the ingredients of a stock.

View Course »